Split donor tissue can be stored for one week

Article

Split donor tissues can be stored for up to one week before DALK and DMEK surgery, according to a paper published in the journal Ophthalmology.

Split donor tissues can be stored for up to one week before DALK and DMEK surgery, according to a paper published in the journal Ophthalmology.

Dr L. M. Heindl et al., Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany, completed a retrospective analysis of a non-randomized consecutive interventonal case series. The study included a total of 220 eyes-110 eyes with anterior stromal disease suitable for DALK and 110 eyes with endothelial disease qualifying for DMEK.

The main outcome measures were best-corrected visual acuity (BSCVA), endothelial cell density and complications rate within 12 months of follow-up. Spearman correlation coefficient and a Mann-Whitney U test was used to analyse the correlation between split donor storage times, total storages times and one-year functional morphologic outcomes.

One year after DALK the mean BSCVA was 20/30, endothelial cell loss was 8% and the complication rate was 18%. The complications included Descemet’s folds, epitheliopathy and loose sutures.

One year after DMEK mean BSCVA was 20/25, endothelial cell loss was 41% and the complication rate was 62%. The complication occurring after DMEK was partial graft detachment.

It is possible for anterior and posterior donor tissue to be stored for up to one week in organ culture before use in surgical procedures. This means the feasibility of split cornea transplantation is simplified because donor shortage and cost will decrease.

To read the paper please visit this link.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.